[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640427":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":47,"collaborators":20,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":20,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"University of Pittsburgh","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Transcutaneous SCS","EXPERIMENTAL","All participants will be receiving transcutaneous spinal cord stimulation",[13],"Device: Transcutaneous stimulator",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Transcutaneous stimulator","an off the shelf TENS unit or Digitimer DS8R (using same parameters as TENS unit)",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Bailey Petersen, PhD","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Sydney Bader, MS","CONTACT","412-648-4196","syb17@pitt.edu",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Pittsburgh","Pennsylvania","15213","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-79.99589,40.44062,{"lat":43,"lon":42},[46],{"name":27,"role":28,"phone":20,"phoneExt":20,"email":30},{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"SPONSOR_INVESTIGATOR","Bailey Petersen","Assistant Professor","100640427","tscs-in-children-with-spina-bifida-100640427",false,"NCT07615686","tSCS in Children With Spina Bifida","Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida","Inclusion Criteria:\n\n* Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist\n* Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and\u002For assistance.\n* Between the ages of 4 and 17 years of age.\n* Documented neurogenic bladder dysfunction\n* On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial\n\nExclusion Criteria:\n\n* Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.\n* Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.\n* Is pregnant. Pregnancy will be assessed via verbal report.\n* Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.\n* Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)\n* Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.","ALL","4 Years","17 Years",{"count":62,"type":63},20,"ESTIMATED","INTERVENTIONAL",[66],"NA","A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.",[69,70],"Spina Bifida","Myelomeningocele",[72,73],"spina bifida","myelomeningocele","2026-05-22",{"date":76,"type":77},"2026-05-29","ACTUAL",{"date":79,"type":63},"2026-06-10",{"date":81,"type":63},"2029-03-10",{"name":49,"class":6},1]